-
21
-
22
Effect of a Ketogenic Diet on Metabolic Dysfunction‐Associated Steatotic Liver Disease (MASLD) Progression: A Randomized Controlled Trial
Published 2025-01-01Subjects: Get full text
Article -
23
LIX1L aggravates MASH-HCC progression by reprogramming of hepatic metabolism and microenvironment via CD36
Published 2025-01-01Subjects: “…MASLD…”
Get full text
Article -
24
Prediction of MASLD using different screening indexes in Chinese type 2 diabetes mellitus
Published 2025-01-01Subjects: “…MASLD…”
Get full text
Article -
25
Association of pan-immune-inflammatory value with metabolic dysfunction-associated steatotic liver disease: findings from NHANES 2017–2020
Published 2025-01-01Subjects: Get full text
Article -
26
Metabolic dysfunction-associated steatotic liver disease and risk of four intrahepatic and extrahepatic diseases
Published 2025-01-01Subjects: “…MASLD/MetALD/ALD…”
Get full text
Article -
27
-
28
A comprehensive analysis of percutaneous liver biopsy characteristics and pathological manifestations in a large patient cohort (2009–2024)
Published 2025-02-01Subjects: Get full text
Article -
29
Impact of liver graft steatosis on long-term post-transplant hepatic steatosis and fibrosis via magnetic resonance quantification
Published 2025-01-01Subjects: “…MASLD…”
Get full text
Article -
30
-
31
-
32
The CYP4/20-HETE/GPR75 axis in the progression metabolic dysfunction-associated steatosis liver disease (MASLD) to chronic liver disease
Published 2025-01-01Subjects: “…MASLD…”
Get full text
Article -
33
Serum dihomo-g-linolenic acid concentration as a potential novel noninvasive biomarker for liver steatosis detection in children
Published 2024-12-01Subjects: Get full text
Article -
34
Altered mitochondrial unfolded protein response and FGF21 secretion in MASLD progression and the effect of exercise intervention
Published 2025-01-01Subjects: Get full text
Article -
35
Associations between systemic inflammatory biomarkers and metabolic dysfunction associated steatotic liver disease: a cross-sectional study of NHANES 2017–2020
Published 2025-01-01Subjects: “…Metabolic dysfunction associated steatotic liver disease (MASLD)…”
Get full text
Article -
36
-
37
The correlation between heavy metal ions in blood and metabolic dysfunction-associated steatotic liver disease from 1999 to 2018 based on NHANES data
Published 2025-01-01Subjects: “…metabolic dysfunction-associated steatotic liver disease (MASLD)…”
Get full text
Article -
38
Inhibition of mmu_circ_0009303 improves metabolic dysfunction-associated steatotic liver disease by regulating lipid metabolism and oxidative stress
Published 2025-01-01Subjects: “…metabolic dysfunction-associated steatotic liver disease (masld)…”
Get full text
Article -
39